4 Unique Challenges of Oncology Trials
Advarra
JUNE 20, 2023
of new cancer drugs tested in Phase I were likely to receive Food and Drug Administration (FDA) approval. Additionally, in 2021, a literature review estimated the average capitalized research and development (R&D) costs per new cancer medicine at between $944 million and $4.54 This means study startup times can vary greatly.
Let's personalize your content